Endostatin is in fact detected in the circulation and BALF of SSc patients and patients with other lung fibrosing diseases, but its levels do not reach therapeutic levels, suggesting a blunted anti-fibrotic response in SSc-associated fibrosis [113,114]. This evidence concerns the gene COL18A1 and systemic sclerosis.